Substance P alterations in skin and brain of chronically stressed atopic-like mice

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 2, 2013, Pages 199-205

  Grip, L ^a   Lonne Rahm, S B ^a   Holst, M ^a   Johansson, B ^a   Nordlind, K ^a   Theodorsson, E ^b   El Nour, H ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NEUROKININ 1 RECEPTOR; SUBSTANCE P;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CELL COUNT; CENTRAL NUCLEUS (AMYGDALA); CHRONIC STRESS; CONTROLLED STUDY; FEMALE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAST CELL DEGRANULATION; MOUSE; NERVE FIBER; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BASE SEQUENCE; BRAIN; CHRONIC DISEASE; DERMATITIS, ATOPIC; DNA PRIMERS; FEMALE; IMMUNOHISTOCHEMISTRY; MICE; POLYMERASE CHAIN REACTION; SKIN; STRESS, PHYSIOLOGICAL; SUBSTANCE P;

EID: 84872682657     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04443.x     Document Type: Article

References (26)

1. Wright RJ, Cohen RT, Cohen S,. The impact of stress on the development and expression of atopy. Curr Opin Allergy Clin Immunol 2005; 5: 23-29.
2. Matsuda H, Watanabe N, Geba GP, et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997; 9: 461-466.
3. Sasakawa T, Higashi Y, Sakuma S, et al. Atopic dermatitis-like skin lesions induced by topical application of mite antigens in NC/Nga mice. Int Arch Allergy Immunol 2001; 126: 239-247.
4. Gutermuth J, Ollert M, Ring J, et al. Mouse models of atopic eczema critically evaluated. Int Arch Allergy Immunol 2004; 135: 262-276.
5. Rosenkranz MA,. Substance P at the nexus of mind and body in chronic inflammation and affective disorders. Psychol Bull 2007; 133: 1007-1037.
6. Severini C, Improta G, Falconierieri-Erspamer G, et al. The tachykinin peptide family. Pharmacol Rev 2002; 54: 285-322.
7. Ebner K, Singewald N,. The role of substance P in stress and anxiety responses. Amino Acids 2006; 31: 251-272.
8. Järvikallio A, Harvima IT, Naukkarinen A,. Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema. Arch Dermatol Res 2003; 295: 2-7.
9. Tobin D, Nabarro G, Baart de la Faille H, et al. Increased number of immunoreactive nerve fibres in atopic dermatitis. J Allergy Clin Immunol 1992; 90: 613-622.
10. Sigura H, Omoto M, Hirota Y, et al. Density and fine structure of peripheral nerves in various skin lesions of atopic dermatitis. Arch Dermatol Res 1997; 289: 125-131.
11. Fantini F, Pincelli C, Romualdi P, et al. Substance P levels are decreased in lesional skin of atopic dermatitis. Exp Dermatol 1992; 1: 127-128.
12. Hägermark Ö, Hökfelt T, Pernow B,. Flare and itch induced by substance P in human skin. J Invest Dermatol 1978; 71: 233-235.
13. Ohmura T, Hayashi T, Satoh Y, et al. Involvement of substance P in scratching behaviour in an atopic dermatitis model. Eur J Pharmacol 2004; 491: 191-194.
14. Toyoda M, Makino T, Kagoura M, Morohashi M,. Immunolocalization of substance P in human skin mast cells. Arch Dermatol Res 2000; 292: 418-421.
15. Ohmura T, Tsunenari I, Hayashi T, et al. Role of substance P in an NC/Nga mouse model of atopic dermatitis-like disease. Int Arch Allergy Immunol 2004; 133: 389-397.
16. Singh LK, Pang X, Alexacos N, et al. Acute immobilization stress triggers skin mast cell degranulation via corticotrophin realeasing hormone, neurotensin and substance P; a link to neurogenic skin disorders. Brain Behav Immun 1999; 13: 225-239.
17. Pavlovic S, Danilitchenko M, Tobin DJ, et al. Further exploring the brain-skin connection: stress worsens dermatitis via substance P-dependent neurogenic inflammation in mice. J Invest Dermatol 2008; 128: 434-436.
18. Lönndahl L, Lonne-Rahm S-B, Nordlind K, et al. Decreased innervation of eczematous skin in NC/Nga atopic mice during chronic mild stress. Immunopharmacol Immunotoxicol 2010; 32: 147-152.
19. 1A autoreceptor desensitization by chronic ultramild stress in mice. NeuroReport 1999; 10: 3369-3374.
20. Buske-Kirschbaum A, Ebrecht M, Hellhammer DH,. Blunted HPA axis responsiveness to stress in atopic patients is associated with the acuity and severeness of allergic inflammation. Brain Behav Immun 2010; 24: 1347-1353.
21. Chen J-H, Wei S-Z, Chen J, et al. Sensory denervation reduces visceral hypersensitivity in adult rats exposed to chronic unpredictable stress: evidences of neurogenic inflammation. Dig Dis Sci 2009; 54: 1884-1891.
22. Czeh B, Simon M, Van der Hart MGC, et al. Chronic stress decreases the number of parvalubin-immunoreactive interneurons in the hippocampus: prevention by treatment with a substance P receptor (NK1) antagonist. Neuropsychopharmacology 2005; 30: 67-79.
23. Bondy B, Baghai TC, Minov C, et al. Substance P serum levels are increased in major depression: preliminary results. Biol Psychiatry 2003; 53: 538-542.
24. Nakaya Y, Kaneko T, Shigemoto R, et al. Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat. J Comp Neurol 1994; 347: 249-274.
25. Duric V, McCarson KE,. Hippocampal neurokinin-1 receptor and brain-derived neurotrophic factor gene expression is decreased in rat models of pain and stress. Neuroscience 2005; 133: 999-1006.
26. Hwang BH, Katner J, Iyengar S,. Corticotropin-releasing factor mRNA and substance P receptor binding in the paraventricular hypothalamic nucleus, central nucleus of the amygdala, locus coeruleus of Sprague-Dawley rats following restraint-induced stress. J Mol Neurosci 2005; 25: 239-250.